Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-21

Clinical Trial Update: Bioavailability Study for New Atorvastatin Formulation [Phase 4]

View source ↗

Summary

Phase 4 bioavailability study of a new atorvastatin formulation completed; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2009-10-21